Abstract
225. NMRA-140, a Novel and Selective Kappa Opioid Receptor Antagonist: Mode of Action Profiling Studies Demonstrate No Opioid Agonist Properties Implicated in Opioid-Related Abuse
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have